AAO-HNS GUIDELINES Bundle (free trial)

Ménière’s Disease

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1226253

Contents of this Issue

Navigation

Page 10 of 21

11 Table 7. IT Steroid Therapy Dosing and Frequency Dose Frequency Dexamethasone sodium phosphate Stock: 4 mg/mL or 10 mg/mL Compounded: 16 mg/mL or 24 mg/mL Inject 0.4–0.8 mL into middle ear space, from once only or up to 3–4 sessions every 3–7 days depending on clinical response. Methylprednisolone sodium succinate Stock: 30 mg/mL or 40 mg/mL Compounded: 62.5 mg/mL Table 8. The American Academy of Otolaryngology-Head and Neck Surgery Hearing Classification Criteria Hearing Category Average PTA Speech Discrimination AAO-HNS Class A ≤30 dB HL >70% B >30– ≤50 dB HL ≥50% C >50 dB HL ≥50% D Any level <50%

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Ménière’s Disease